Mercado global de imagiologia médica – Tendências do setor e previsão para 2030

Análise e tamanho do mercado de imagens médicas

As imagens médicas referem-se a técnicas de geração de imagens do corpo humano (ou de partes específicas do corpo) para diversas aplicações clínicas, tais como procedimentos e diagnósticos, bem como para a ciência médica, que inclui a investigação de anatomia e função típicas. Esta categoria de imagens biológicas inclui a radiografia, a endoscopia, a termografia, a fotografia médica e a microscopia   num sentido mais geral. As imagens médicas incluem métodos de medição e registo, como a eletroencefalografia (EEG) e a magnetoencefalografia (MEG), produzindo dados visualizados como mapas em vez de imagens.

A Data Bridge Market Research analisa que o mercado de imagiologia médica, avaliado em 21,24 mil milhões de dólares em 2022, atingirá os 33,08 mil milhões de dólares até 2030, crescendo a um CAGR de 5,69% durante o período de previsão de 2023 a 2030. Além dos insights sobre o mercado cenários como o valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de imagens médicas  

Market Definition

The term "medical imaging" refers to several different technologies used to view the human body to monitor, diagnose, or treat medical conditions. Each type of technology offers specific information about potential illnesses, damage to the body part being studied or treated, or the effectiveness of medical treatment. Through the visual representation of tissues and organs, medical imaging aims to represent the body's interior for clinical diagnosis and medical intervention.

Medical Imaging Market Dynamics

Drivers

• Rise in the prevalence of chronic illnesses

The global market for medical imaging reagents is driven by the development of products and the significant unmet need for diagnostic imaging procedures and diseases such as cancer and cardiovascular disease. For instance, cardiovascular disease is one of the main causes of death worldwide. Furthermore, because older people are more likely to develop chronic diseases, the growing geriatric population is anticipated to increase the demand for medical imaging reagents. The widespread occurrence of numerous chronic diseases among people has also been linked to a sizeable portion of the market's robust growth.

• Increasing demand for advanced diagnostic imaging

Imaging techniques are needed to detect structural abnormalities and pathological changes in the body because traumatic injuries are common and frequent. Imagine techniques have been used to detect the minor changes the human eye cannot detect. With the aid of an advanced diagnostic system, a precise diagnosis of the patient's condition can be made, making choosing the best course of treatment. Thus the market is expanding due to the rise in cancer patients who require sophisticated imaging reagents and diagnostic imaging techniques for a more precise diagnosis, such as photoacoustic imaging.

Opportunities

• Adoption of AI technology can create the growth

Artificial intelligence-enhanced imaging techniques are created to help medical professionals accurately assess patients' conditions and choose how to best proceed with their care. Teaching hospitals have taken several measures to ensure that the medical staff is adequately trained to use cutting-edge technology, which is crucial to the health care industry. Throughout the forecast period, the adoption of artificial intelligence in imaging techniques has improved outcomes and accelerated market growth.

• Improvement in governmental standards and policies regarding helping the market grow

The market for medical imaging has also been boosted by the improvement in governmental standards and policies regarding the reimbursement services provided to patients. The attractive reimbursement options offered by insurance companies have significantly increased the market. To entice customers to purchase larger policies, insurance companies work tirelessly to give them the best amenities, further propelling market growth.

Restraints/Challenges

• Less adoption of advanced imaging equipment limits the growth

Factors include decreased imaging volumes, economic hardships resulting in less adoption of advanced imaging technology, staff reductions at radiology centers and hospitals, and a rise in teleradiology services. Additionally, computer vision is used to identify invisible diseases to the human eye. Despite technical advancements and a rise in the use of sophisticated imaging tools, the market experienced a decline. However, the market expansion is constrained by the high cost of medical diagnostic/imaging devices and the unfavorable reimbursement environment of advanced imaging equipments.

• Hospital's selective behavior limits the expansion

The hospital's selective behavior regarding the procedures carried out to prevent cross-infection to the patient and the medical staff negatively impacts the market. Hospitals avoided routine checkups and follow-ups to reduce the risk of disease transmission and only dealt with severe cases. As a result, orthopedic patients are used in imaging procedures less frequently. The rising risk of patients scanned using the same imaging equipment as the other infected patients have severely restricted the market's growth.

Este relatório de mercado de imagiologia médica fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado nacionais e localizados, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações no mercado regulamentações, análise estratégica de crescimento de mercado, tamanho de mercado, crescimento de mercado de categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado de imagens médicas, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Desenvolvimentos recentes

• Em 2022, a Nordisk Rontgen Teknik será adquirida pela Canon Medical System, de acordo com o anúncio. Um fabricante de renome de sistemas de diagnóstico por raios X é a Nordisk Rontgen Tetnik. A capacidade da empresa de operar globalmente na indústria de raios X foi auxiliada por esta aquisição.
• Em 2022, a Siemens Healthineers apresentou o seu novo MANGETOM free star e NAETOM alpha em pipelines de ressonância magnética e tomografia computorizada na 74ª Conferência Nacional IRIA 2022 em Bengaluru. Como ofereciam tecnologia de ponta em imagiologia médica, estes produtos ajudaram a empresa a aumentar a sua base de clientes.
• Em 2021, o ultrassom de bolso sem fios Vscan AirTM de última geração da GE Healthcare oferece aos médicos uma qualidade de imagem brilhante, capacidades de digitalização de corpo inteiro e software fácil de utilizar.
• Em 2021, a Esaote North America disponibilizou o sistema de ecografia MyLab X8 no Canadá. O sistema de imagem premium MyLab X8 oferece uma gama completa de funcionalidades, integra os mais recentes avanços tecnológicos e produz imagens de maior qualidade sem sacrificar a produtividade ou a eficiência. No passado, a FDA dos Estados Unidos aprovou-o.

Âmbito global do mercado de imagens médicas

O mercado de imagiologia médica está segmentado com base em procedimentos, tecnologia, modalidade, tipo de paciente, aplicação e utilizadores finais. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.

Procedimento

• Imagem de raios X
• Digital
• Radiologia Digital Direta
• Radiologia Computadorizada
• Analógico
• Tomografia Computadorizada (TC)
• Imagem por ressonância magnética (RM)
• Ultrassom
• Ecografia 2D
• Ultrassom 3D
• Outros
• Imagiologia Nuclear (SPECT/PET)
• Mamografia
• Imagem Molecular
• Outros

Tecnologia

• Radiologia Digital Direta
• Radiologia Computadorizada

Modalidade

• Estacionário
• Portátil

Tipo de paciente

• Adultos
• Pediátrico

Aplicação

• Imagem Geral
• Torácico
• Cardiologia
• Obstetrícia
• Ortopedia e músculo-esquelética
• Neuro e coluna
• Pélvico e Abdominal
• Oncologia
• Radiografia
• Fluoroscopia
• Ginecologia
• Saúde da mama
• Urologia
• Musculoesquelético
• Dental
• Outros

Utilizadores finais

• Hospitais
• Centros de Diagnóstico
• Centros de imagiologia
• Clínicas Especializadas
• Centros Cirúrgicos Ambulatoriais
• Institutos Académicos e de Investigação
• Outros

Análise/perspetivas regionais do mercado de imagiologia médica

The Medical Imaging Market is analysed and market size insights and trends are provided by country, procedures, technology, modality, patient type, application and end users as referenced above.

The countries covered in the Medical Imaging Market report are  U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are changing consumer preferences and expanding consumer spending patterns. Additionally, it is anticipated that improvements and the growth of several production industries will aid in developing the rubber compound industry.

Asia-Pacific will undergo the highest growth rate during the forecast period owing to an increasing number of businesses in emerging nations. Furthermore, the number of businesses in emerging nations is increasing due to the demand for diagnostics in clinics, hospitals, and other industries. In addition, the number of hospitals and clinical diagnostic labs in China and India and rising healthcare spending are causing a rise in demand for medical imaging.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Medical Imaging Market Share Analysis

The Medical Imaging Market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Medical Imaging Market.

Some of the major players operating in the medical imaging market are:

• Koninklijke Philips N.V. (Netherlands)
• (Canadá)
• Grupo InHealth (Reino Unido)
• Siemens Healthcare GmbH (Alemanha)
• Sonic Healthcare Limited (Austrália)
• GE HealthCare (EUA)
• (EUA)
• (EUA)
• Corporação Shimadzu (Japão)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• CANON MEDICAL SYSTEMS CORPORATION (Japão)
• ZEISS (Alemanha)
• Corporação FUJIFILM (Japão)
• Hitachi, Ltd. (Japão)
• Carestream Saúde (EUA)
• UNILABS (Suíça)
• ONRAD, Inc.
• Narang Medical Limited (Índia)
• Johnson & Johnson Services, Inc (EUA)
• BD (EUA)

SKU-52358